CONTACT US
A World-Class Team for a Global Mission.
Executing a mission on this scale requires leadership with deep experience, global perspective, and unwavering dedication.
• Nominated for 2025 Galien Award – Best Startup
• Recognized as a Top 10 Drug Discovery & Development Solutions Provider in Europe (Life Sciences Review, 2023).
• CEO Thomas Lines featured in The Silicon Review for leadership in global health innovation.
• Upcoming:
o Phase III trial initiation for Kinisoquin™ in cancer-associated thrombosis.
o Phase III in Sickle Cell Disease
o Phase II trial with Administration for Strategic Preparedness and Response (ASPR)
